摘要
目的:分析重组假丝酵母尿酸酶中聚合物的形成原因及其对结构功能的影响。方法:通过分子排阻高效液相色谱(SEC-HPLC)结合多角度激光散射仪分离聚合物并测定其相对分子质量;将含有聚合物的蛋白进行还原及非还原十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE),确定聚合物的形成是否与二硫键有关;通过液质联用仪鉴定聚合物中存在的二硫键;通过测定圆二色谱评价聚合物的形成对蛋白二级结构的影响;通过多角度激光散射仪测定二硫键形成对蛋白稳定性的影响;通过酶活性测定评价聚合物形成对酶活性的影响。结果:重组假丝酵母尿酸酶正常以同源四聚体的形式存在,37℃条件下可通过链间二硫键形成更高级别的聚合物,高级聚合物的形成对蛋白二级结构及稳定性的影响不大,但会降低酶活性。结论:本文综合多种手段对尿酸酶中聚合物的成因及影响进行分析,测定结果可为该制品的后续研究及质量控制提供依据。
Objective:To analyze the cause of polymers in recombinant Candida uricase and its effect on structure and function. Methods:The polymers were separated by size exclusion-high performance liquid chromatography(SEC-HPLC) combined with multi-angle laser light scattering(MALLS) to measure their relative molecular weights. The proteins containing polymers were analyzed by reduced and non-reduced sodium dodecyl sulphate-polyacrylamide gel electrophoresis(SDS-PAGE) to determine whether the formation of polymers was related to disulfide bonds. The disulfide bonds in the polymers were identified by liquid chromatography-mass spectrometry(LC-MS);The influence of polymers formation on secondary structure of protein was evaluated by circular dichroism. The disulfide bonds' effect on thermal stability of protein was determined by MALLS. The enzyme activity was also measured to determine whether it was affected by polymerization. Results:The protein normally exists in the form of homologous tetramers,and higher level polymers can be formed gradually through inter-chain disulfide bonds at 37 ℃. The formation of higher level polymers has no significant effect on secondary structure and stability of protein,but it could reduce its enzyme activity. Conclusion:The causes and effects of polymers in uricase were analyzed by various methods,which can provide basis for the follow-up research and quality control of the products.
作者
陶磊
丁有学
李永红
韩春梅
史新昌
裴德宁
饶春明
TAO Lei;DING You-xue;LI Yong-hong;HAN Chun-mei;SHI Xin-chang;PEI De-ning;RAO Chun-ming(National Institutes for Food and Drug Control,Key Laboratory of Ministry of Health for Research on Quality and Standardization of Biotech Products,Beijing 100050,China)
出处
《药物分析杂志》
CAS
CSCD
北大核心
2018年第11期1893-1898,共6页
Chinese Journal of Pharmaceutical Analysis
基金
药品医疗器械审评审批制度改革专项课题(ZG2017-3-02)
十三五科技重大专项课题"生物类似药质量相似性评价体系建设研究"(2015ZX09501008)